Kertesz A, Clydesdale S
Department of Clinical Neurological Sciences, St Joseph's Hospital, Lawson Research Institute, University of Western Ontario, London.
Arch Neurol. 1994 Dec;51(12):1226-31. doi: 10.1001/archneur.1994.00540240070018.
To detect neuropsychological differences between Alzheimer's disease (AD) and vascular dementia (VAD).
Neuropsychological measures were compared in clinically defined AD and VAD patient groups.
Ambulatory and hospitalized patients were referred to a behavioral neurology clinic and to the neuropsychology department of a teaching hospital.
Consecutive, referred patients who fulfilled National Institute of Neurological Disorders and Stroke/Alzheimer's Disease and Related Disorders Association and Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, criteria for AD and VAD were selected to participate in the study based on the history and clinical findings. A modified ischemic score of 3 or less was an independent selection criterion for AD (n = 103) and a score of 4 or more for VAD (n = 25). Computed tomography or magnetic resonance imaging was used to exclude other structural causes. Patients with cognitive changes related directly to a stroke were excluded. Patients were matched for age, education, age at onset, and severity of dementia.
The variable measures were the subtests of the Wechsler Adult Intelligence Scale-Revised (WAIS-R), Wechsler Memory Scale-Revised, Mattis Dementia Rating Scale (MDRS), and Western Aphasia Battery (WAB). Patients were further stratified into mild and severe dementia categories, based on their performance on the MDRS.
Variables that were significantly different were selected for discriminant function analysis. The Writing subtest of the WAB, the Picture Arrangement subtest of the WAIS-R, and the Motor Performance subtest of the MDRS were the best discriminators of AD and VAD in the overall and severely affected populations. Patients with VAD performed significantly worse on the MDRS Motor Performance subtest, the WAIS-R Picture Arrangement subtest, the WAB Writing subtest, the WAIS-R Object Assembly subtest, and the WAB Block Design subtest. The AD group performed significantly worse on the WAB Repetition subtest, and patients with severe AD performed significantly worse on the Story Recall test.
Patients with VAD performed worse on tests that are influenced by frontal and subcortical mechanisms. Patients with AD performed worse on memory and some language subtests.
检测阿尔茨海默病(AD)与血管性痴呆(VAD)之间的神经心理学差异。
对临床确诊的AD和VAD患者组进行神经心理学测量比较。
门诊和住院患者被转诊至一家行为神经科诊所及一家教学医院的神经心理学科室。
根据病史和临床检查结果,连续入选符合美国国立神经疾病与中风研究所/阿尔茨海默病及相关疾病协会及《精神疾病诊断与统计手册》第三版修订版中AD和VAD标准的转诊患者。改良缺血评分3分及以下是AD(n = 103)的独立入选标准,4分及以上是VAD(n = 25)的入选标准。采用计算机断层扫描或磁共振成像排除其他结构性病因。直接与中风相关的认知改变患者被排除。患者在年龄、教育程度、发病年龄和痴呆严重程度方面进行匹配。
变量测量包括韦氏成人智力量表修订版(WAIS-R)、韦氏记忆量表修订版、马蒂斯痴呆评定量表(MDRS)和西方失语成套测验(WAB)的子测验。根据患者在MDRS上的表现,进一步将患者分为轻度和重度痴呆类别。
选择差异有统计学意义的变量进行判别函数分析。WAB的书写子测验、WAIS-R的图片排列子测验和MDRS的运动表现子测验是总体人群和重度受影响人群中AD和VAD的最佳判别指标。VAD患者在MDRS运动表现子测验、WAIS-R图片排列子测验、WAB书写子测验、WAIS-R物体拼凑子测验和WAB积木图案子测验上的表现明显更差。AD组在WAB复述子测验上的表现明显更差,重度AD患者在故事回忆测验上的表现明显更差。
VAD患者在受额叶和皮质下机制影响的测验中表现更差。AD患者在记忆和一些语言子测验上表现更差。